CiNii Articles

1

Cutaneous toxicities of immune checkpoint inhibitors [in Japanese]

佐藤さゆり , 宇原久

臨床免疫・アレルギー科 = Clinical immunology & allergology 75(4), 402-409, 2021-04
2

Cancer immunotherapy with immune checkpoint inhibitors [in Japanese]

西岡安彦

日本内科学会雑誌 110(3), 520-525, 2021-03-10
3

JCOG2007 [in Japanese]

白石祥理 , 岡本勇

腫瘍内科 = Clinical oncology 27(3), 356-360, 2021-03
4

Immune-related adverse events in pituitary glands [in Japanese]

岩間信太郎 , 有馬寛

医学のあゆみ 276(8), 782-785, 2021-02-20

Ichushi Web
5

Differential diagnosis of immune-related adverse events [in Japanese]

須藤洋崇 , 清田尚臣

医学のあゆみ 276(8), 765-769, 2021-02-20

Ichushi Web
6

Immune-related adverse event of immune checkpoint inhibitors [in Japanese]

山下万貴子

医学のあゆみ 276(8), 756-759, 2021-02-20

Ichushi Web
7

Combination therapy of PD-1 inhibitor and CTLA-4 inhibitor for renal cell carcinoma [in Japanese]

五十嵐大樹 , 加藤廉平 , 小原航

臨床泌尿器科 = Japanese journal of clinical urology 75(2), 102-108, 2021-02
8

皮膚を病変の場とするirAEの病態と対処法 (特集免疫再構築症候群/irAEの学び方・診方) [in Japanese]

加藤雪彦

デルマ (305), 63-69, 2021-02
9

メラノーマ治療におけるirAEの病態と対処法 (特集免疫再構築症候群/irAEの学び方・診方) [in Japanese]

中村泰大 , 寺本由紀子

デルマ (305), 55-61, 2021-02
10

非HIV免疫再構築症候群とirAEに共通する免疫機構 (特集免疫再構築症候群/irAEの学び方・診方) [in Japanese]

松井聖

デルマ (305), 9-16, 2021-02
11

免疫チェックポイント阻害薬を含む標準治療 : 肺がん (ここまできたがん免疫療法) [in Japanese]

水谷友紀

杏林医学会雑誌 = Journal of the Kyorin Medical Society, 121-125, 2021-01
12

Immunotherapy in Colorectal Cancer: Current and Future Strategies

Ooki Akira , Shinozaki Eiji , Yamaguchi Kensei

<p>Despite the recent advances in the systemic treatment of metastatic colorectal cancer (mCRC), prognostic outcomes have remained to be poor. Thus, what is needed is an innovative treatment app …

Journal of the Anus, Rectum and Colon 5(1), 11-24, 2021

J-STAGE
13

Differentially expressed in FDCP6 homolog (DEF6) deficiency [in Japanese]

小林一郎

日本臨床 = Japanese journal of clinical medicine 78(1190増刊7), 239-241, 2020-12

Ichushi Web
14

Immune checkpoint inhibitors : Regulation of anti-tumor T-cell immunity [in Japanese]

岩井佳子

医学のあゆみ 275(5), 440-444, 2020-10-31
15

Immune checkpoint inhibitor-related colitis [in Japanese]

千代大翔 , 小原英幹 , 藤原新太郎 , 西山典子 , 中谷夏帆 , 正木勉

消化器・肝臓内科 = Gastroenterology & hepatology 8(4), 334-340, 2020-10

Ichushi Web
16

Developmental status for malignant pleural mesothelioma including immunotherapy [in Japanese]

木島貴志

呼吸器内科 = Respiratory medicine 38(2), 163-169, 2020-08

Ichushi Web
17

Cancer treatment by I-O/I-O combination [in Japanese]

北野滋久

腫瘍内科 = Clinical oncology 26(1), 40-48, 2020-07

Ichushi Web
18

Immune monitoring with the peripheral blood [in Japanese]

各務博

腫瘍内科 = Clinical oncology 26(1), 26-32, 2020-07

Ichushi Web
19

Recent Advances in Immunotherapy for Hepatocellular Carcinoma

Nakano Shigeharu , Eso Yuji , Okada Hirokazu , Takai Atsushi , Takahashi Ken , Seno Hiroshi

Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related death since most patients are diagnosed at advanced stage and the current systemic treatment options using molecular-targe …

Cancers 12(4), 2020-04-01

IR
20

Insight into innate immune response in "Yusho": The impact of natural killer cell and regulatory T cell on inflammatory prone diathesis of Yusho patients

Kamio Yoshiyuki , Gunge Yumi , Koike Yuta , Kuwatsuka Yutaka , Tsuruta Kazuto , Yanagihara Katsunori , Furue Masutaka , Murota Hiroyuki

… Conversely, serum cytotoxic T lymphocyte-associated antigen-4 (CTLA-4), which is a cytokine related to activated NK cells, was higher in Yusho patients than in healthy subjects and was positively correlated with PCDF blood levels. … The seemingly paradoxical results for CTLA-4 and IFN-γ may reflect counterbalancing mechanisms preventing excessive NK cell activation. …

Environmental Research (185), 109415, 2020-03-21

IR

Search Results 1-20 of 609

Related Authors

Related Journals